| Endocrine aspects of male sexual dysfunctions J Buvat, M Maggi, L Gooren, AT Guay, J Kaufman, A Morgentaler, ... The journal of sexual medicine 7 (4_Part_2), 1627-1656, 2010 | 281 | 2010 |
| Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of … J Buvat, F Montorsi, M Maggi, H Porst, A Kaipia, MH Colson, B Cuzin, ... The journal of sexual medicine 8 (1), 284-293, 2011 | 204 | 2011 |
| Long‐term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health‐related quality … DJ Yassin, G Doros, PG Hammerer, AA Yassin The journal of sexual medicine 11 (6), 1567-1576, 2014 | 196 | 2014 |
| A dose‐response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate F Saad, LJ Gooren, A Haider, A Yassin Journal of Andrology 29 (1), 102-105, 2008 | 194 | 2008 |
| Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone AA Yassin, F Saad, LJ Gooren Andrologia 40 (4), 259-264, 2008 | 191 | 2008 |
| Effects of long‐term testosterone therapy on patients with “diabesity”: results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes A Haider, A Yassin, G Doros, F Saad International journal of endocrinology 2014 (1), 683515, 2014 | 170 | 2014 |
| Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies F Saad, A Yassin, G Doros, A Haider International journal of obesity 40 (1), 162-170, 2016 | 166 | 2016 |
| Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study A Yassin, A Haider, KS Haider, M Caliber, G Doros, F Saad, WT Garvey Diabetes Care 42 (6), 1104-1111, 2019 | 156 | 2019 |
| Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only AA Yassin, F Saad The journal of sexual medicine 4 (2), 497-501, 2007 | 154 | 2007 |
| Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries A Haider, M Zitzmann, G Doros, H Isbarn, P Hammerer, A Yassin The Journal of urology 193 (1), 80-86, 2015 | 146 | 2015 |
| Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss AA Yassin, G Doros Clinical obesity 3 (3-4), 73-83, 2013 | 129 | 2013 |
| Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports AA Yassin, F Saad, A Traish The journal of sexual medicine 3 (4), 727-735, 2006 | 126 | 2006 |
| An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome F Saad, L Gooren, A Haider, A Yassin Archives of Andrology 53 (6), 353-357, 2007 | 122 | 2007 |
| The evolving role of testosterone in the treatment of erectile dysfunction R Shabsigh, J Rajfer, A Aversa, AM Traish, A Yassin, SY Kalinchenko, ... International journal of clinical practice 60 (9), 1087-1092, 2006 | 120 | 2006 |
| Sex‐based differences in severity and mortality in COVID‐19 M Alwani, A Yassin, RM Al‐Zoubi, OM Aboumarzouk, J Nettleship, D Kelly, ... Reviews in medical virology 31 (6), e2223, 2021 | 116 | 2021 |
| Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters A Yassin, JE Nettleship, RA Talib, Y Almehmadi, G Doros The Aging Male 19 (1), 64-69, 2016 | 116 | 2016 |
| Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes A Haidar, A Yassin, F Saad, R Shabsigh The Aging Male 10 (4), 189-196, 2007 | 112 | 2007 |
| Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of … FMJ Debruyne, HM Behre, CG Roehrborn, M Maggi, FCW Wu, ... BJU international 119 (2), 216-224, 2017 | 104 | 2017 |
| Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple … H Van Ahlen, K Wahle, W Kupper, A Yassin, T Reblin, M Neureither The Journal of Sexual Medicine 2 (6), 856-864, 2005 | 99 | 2005 |
| Amelioration of penile fibrosis: myth or reality AI El‐Sakka, AA Yassin Journal of Andrology 31 (4), 324-335, 2010 | 91 | 2010 |
Yousef AlmehmadiKing Abdulaziz University在 kau.edu.sa 的电子邮件经过验证
